Tost, J. Et Al. 2025. Leveraging epigenetic alterations in pancreatic ductal adenocarcinoma for clinical applications. Seminars in Cancer Biology , vol.109 , 101-124.

Tost, J., Ak-Aksoy, S., Campa, D., Corradi, C., Farinella, R., Ibáñez-Costa, A., ... Dubrot, J.(2025). Leveraging epigenetic alterations in pancreatic ductal adenocarcinoma for clinical applications. Seminars in Cancer Biology , vol.109, 101-124.

Tost, Jorg Et Al. "Leveraging epigenetic alterations in pancreatic ductal adenocarcinoma for clinical applications," Seminars in Cancer Biology , vol.109, 101-124, 2025

Tost, Jorg Et Al. "Leveraging epigenetic alterations in pancreatic ductal adenocarcinoma for clinical applications." Seminars in Cancer Biology , vol.109, pp.101-124, 2025

Tost, J. Et Al. (2025) . "Leveraging epigenetic alterations in pancreatic ductal adenocarcinoma for clinical applications." Seminars in Cancer Biology , vol.109, pp.101-124.

@article{article, author={Jorg Tost Et Al. }, title={Leveraging epigenetic alterations in pancreatic ductal adenocarcinoma for clinical applications}, journal={Seminars in Cancer Biology}, year=2025, pages={101-124} }